Lieff Cabraser partner Wendy R. Fleishman will be speaking at the Practising Law Institute’s “Women Lawyers in Leadership” seminar on January 26, 2018 at the PLI New York Center in New York City. As PLI describes the program, “Although the glass ceiling has cracks, there are still obstacles to its complete shatter. More women are needed in leadership positions in the legal profession. Despite equal numbers of women entering the legal profession, female attorneys still lag in equity partnerships and leadership positions.” [Read more…]
LFIT V40 Femoral Head Recall
The Judicial Panel on Multidistrict Litigation (JPMDL) has created new MDL No. 2768 to hear products liability litigation involving the Stryker-branded LFIT Anatomic CoCR V40 femoral heads, a prosthetic hip replacement device. [Read more…]
On Monday, April 3, 2017, Lieff Cabraser attorney Wendy Fleishman will speak at the Mass Torts Judicial Conference presented by JAMS mediation, arbitration, and dispute resolution service and featuring the Honorable Marina Corodemus (ret.). Covering topics including E-Discovery, Discrimination, the Media, Jurisdiction, and Ethics, the day-long program was assembled and arranged by Judge Corodemus, who hand-picked the speakers and will run the conference event. [Read more…]
Lieff Cabraser attorney Wendy R. Fleishman will be speaking at the Mass Torts Judicial Forum presented by HB Litigation Conferences on April 15, 2016 at The Roosevelt Hotel in New York. Ms. Fleishman will be a featured speaker on the panel titled “Settling Strategies for MDLs: Getting Started, Setting Values and Overcoming Obstacles.” [Read more…]
New York, NY, August 24, 2015 — Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announces that the firm has published an informational video on IVC blood clot filter injuries and a list of Answers to Frequently Asked Questions About IVC Blood Filters concerning alleged defects in certain retrievable inferior vena cava (IVC) blood filters.
Lieff Cabraser attorney Wendy R. Fleishman has recently been elected to the Board of Governors of the American Association for Justice (AAJ). Fleishman also serves as a leader of the AAJ’s Women’s Caucus. Promoting a fair and effective justice system, AAJ’s mission is to support the representation of those injured by the harmful misconduct and negligence of others.
Patients charge that Xarelto is a dangerous and defective drug because in certain patients it triggers uncontrolled bleeding and other life-threatening complications. Xarelto was approved in July 2011 to prevent blood clots in patients undergoing knee and hip surgeries, and its use has been expanded, including to patients with irregular heartbeats or facing a strong likelihood of blood clots in the legs or lungs.
Lieff Cabraser attorneys Wendy R. Fleishman and Lexi J. Hazam have been chosen by the American Association for Justice for inclusion in their 2015 Leadership Academy. An initiative of AAJ’s Diversity Committee, the Leadership Academy selects 12 plaintiff trial lawyers from different backgrounds and practice areas to develop their leadership roles within AAJ through workshops, training sessions, and conventions.
Lieff Cabraser attorney Wendy R. Fleishman is serving as the chair and moderator of a program on Toxic, Environmental, and Pharmaceutical Torts at the annual convention of the American Association for Justice in Baltimore, Maryland on July 27, 2014. The program will bring many of the nation’s leading plaintiffs’ attorneys to review in depth the methods and practices of achieving justice for large numbers of claimants in mass torts cases, including comparing federal multidistrict litigation with state coordinated litigation.